NCT00004046View on ClinicalTrials.gov

Chemotherapy in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 1999

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions

Breast Cancer

Interventions

DRUG

exatecan mesylate

Trial Locations (1)

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY